Analysts have lowered their price target for Angi from $20.50 to $19.88, citing slight decreases in profit margin and revenue growth projections as key factors in the reassessment.
What's in the News
- Angi repurchased 2,081,001 shares between July 1, 2025 and October 31, 2025. This represents 4.61 percent of shares and $33.43 million.
- The company completed the repurchase of 5 million shares for a total of $79.9 million, amounting to 10.5 percent of outstanding shares. This was part of the buyback announced on May 6, 2025. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has decreased from $20.50 to $19.88, reflecting a modest reduction in fair value estimates.
- The discount rate has risen slightly from 11.24% to 11.33%.
- The revenue growth projection has fallen modestly, moving from 2.87% to 2.85%.
- The net profit margin estimate has decreased marginally from 5.41% to 5.36%.
- The future P/E ratio forecast has dipped from 15.40x to 15.13x.
Have other thoughts on Angi?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.